AI Article Synopsis

  • COVID-19 has led to a rise in opportunistic fungal infections, particularly mucormycosis, which presents significant health risks globally.
  • A study at Datta Meghe Institute involved 55 COVID-19 patients with mucormycosis and 50 control patients, revealing a strong association between zinc intake and the fungal infection, as well as a notable correlation with diabetes mellitus.
  • The findings suggest that while diabetes and immunosuppressive conditions contribute to mucormycosis, excessive zinc usage may also play a critical role, warranting more research to confirm these associations.

Article Abstract

Introduction Coronavirus disease 2019 (COVID-19)has been a difficult enemy to beat for healthcare professionals around the world. However, even before the end of the COVID-19 pandemic, there has been an emergence of a new combatant in the form of opportunistic fungal infections with a high rate of morbidity and mortality, creating havoc throughout the globe. Methods A case-control single-center study was conducted in Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra. All the subjects who were included in the study were tested positive for COVID-19 through the reverse transcriptase-polymerase chain reaction (RT-PCR) method and the cases were defined as patients with biopsy-proven mucormycosis, whereas control were subjects who did not develop mucormycosis. The duration of the study was three months, from June 2021 to August 2021. Result A total of 55 cases and 50 controls were enrolled in the study. The use of zinc was found to be significantly associated with COVID-19-associated mucormycosis, with 89.1% of the cases having a history of zinc intake and only 52% of controls having a history of zinc intake( p-value <0.001). Diabetes mellitus was found to be significantly associated with COVID-19-associated mucormycosis with 83.6% of the cases and 16% of the controls having diabetes mellitus (p-value <0.001). Although the use of steroids in cases was more with 98.2% of the cases and 54% of the control receiving steroids; this difference was not significant statistically (p-value of 1.00). Conclusion We conclude that apart from diabetes mellitus and other immunosuppressive states, zinc might be the hidden culprit behind the sudden surge of COVID-19-associated mucormycosis worldwide owing to the self-administration of zinc by the patients to acquire innate immunity and over-prescription of multivitamins by the treating clinicians. However, this association required further studies in order to be proved.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955911PMC
http://dx.doi.org/10.7759/cureus.22528DOI Listing

Publication Analysis

Top Keywords

covid-19-associated mucormycosis
8
history zinc
8
zinc intake
8
role zinc
4
zinc clinicopathological
4
clinicopathological factors
4
factors covid-19-associated
4
mucormycosis
4
mucormycosis cam
4
cam rural
4

Similar Publications

Article Synopsis
  • COVID-19-related mucormycosis in India led to significant maxillectomy cases, prompting this study on post-surgery quality of life through prosthodontic rehabilitation.
  • The research utilized questionnaire-based interviews with the Oral Health Impact Profile-14 (OHIP-14) and Obturator Functioning Scale (OFS) to assess changes in patients' quality of life before and after receiving interim obturators.
  • Results indicated significant improvements in patients' quality of life, including better speech, swallowing, and psychological well-being post-rehabilitation, highlighting the importance of obturators in recovery.
View Article and Find Full Text PDF

Functional Rehabilitation - an Integral Component for Quality of Life in the Holistic Management of COVID-19 Associated Mucormycosis.

Indian J Otolaryngol Head Neck Surg

December 2024

Department of Dentistry, Oral and Maxillofacial Surgery, All India Institute of Medical Sciences, Room no 211, 2A, OPD block, Jodhpur, 342005 Rajasthan India.

To evaluate the quality of life in the post maxillectomy patients due to Coronavirus disease 2019 (COVID-19) associated Mucormycosis (CAM) following rehabilitation with obturators. The study also described the management and treatment outcomes of CAM patients. The study included 80 confirmed patients of CAM.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focused on the severe impact of COVID-19-associated mucormycosis in India, particularly how it leads to significant maxillofacial defects requiring surgical intervention and antifungal treatments.
  • - Researchers evaluated eight patients who underwent single-stage delayed free flap reconstruction, measuring outcomes related to quality of life, aesthetics, and speech at one and three months post-surgery.
  • - Results showed notable improvements in patients' quality of life and aesthetics over three months, indicating that this surgical approach is beneficial for those affected by rhino-orbito-maxillary defects.
View Article and Find Full Text PDF

Introduction: Coronavirus disease 2019 (COVID-19) has been associated with secondary fungal infections such as mucormycosis. We investigated the relapse rate of mucormycosis and its risk factors.

Methodology: A prospective study was conducted on COVID-19-associated mucormycosis (CAM) patients discharged from Imam Khomeini Hospital Complex, Tehran, Iran, from July 2021 to February 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!